CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common stock	Treasury Stock	Additional paid-in capital	Accumulated other comprehensive loss	Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2023		19,183,046
Beginning balance at Dec. 31, 2023	$ 210,489	$ 1	$ (13,000)	$ 1,197,963	$ (7)	$ (974,468)
Beginning balance (in shares) at Dec. 31, 2023			2,314,908
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon release of restricted stock units (in shares)		64,020
Issuance of common stock upon exercise of stock options (in shares)		566
Shares withheld related to net share settlement (in shares)		(229)
Shares repurchased by the Company and held as treasury stock (in shares)		(1,209,549)	(1,209,549)
Shares repurchased by the Company and held as treasury stock	(6,956)		$ (6,956)
Other comprehensive income	6				6
Stock-based compensation	8,740			8,740
Net income (loss)	(26,723)					(26,723)
Ending balance (in shares) at Mar. 31, 2024		18,037,854
Ending balance at Mar. 31, 2024	185,556	$ 1	$ (19,956)	1,206,703	(1)	(1,001,191)
Ending balance (in shares) at Mar. 31, 2024			3,524,457
Beginning balance (in shares) at Dec. 31, 2023		19,183,046
Beginning balance at Dec. 31, 2023	210,489	$ 1	$ (13,000)	1,197,963	(7)	(974,468)
Beginning balance (in shares) at Dec. 31, 2023			2,314,908
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income	7
Net income (loss)	(21,793)
Ending balance (in shares) at Sep. 30, 2024		17,868,489
Ending balance at Sep. 30, 2024	199,463	$ 1	$ (23,905)	1,219,628	0	(996,261)
Ending balance (in shares) at Sep. 30, 2024			4,133,469
Beginning balance (in shares) at Mar. 31, 2024		18,037,854
Beginning balance at Mar. 31, 2024	185,556	$ 1	$ (19,956)	1,206,703	(1)	(1,001,191)
Beginning balance (in shares) at Mar. 31, 2024			3,524,457
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased by the Company and held as treasury stock (in shares)		(589,721)	(589,721)
Shares repurchased by the Company and held as treasury stock	(3,814)		$ (3,814)
Stock issued under employee stock purchase plan (in shares)		1,195
Stock issued under employee stock purchase plan	7			7
Other comprehensive income	1				1
Stock-based compensation	7,433			7,433
Net income (loss)	26,045					26,045
Ending balance (in shares) at Jun. 30, 2024		17,449,328
Ending balance at Jun. 30, 2024	215,228	$ 1	$ (23,770)	1,214,143	0	(975,146)
Ending balance (in shares) at Jun. 30, 2024			4,114,178
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon release of restricted stock units (in shares)		628,458
Issuance of common stock upon exercise of stock options (in shares)		1,235
Shares withheld related to net share settlement (in shares)		(191,241)
Shares withheld related to net share settlement	(1,236)			(1,236)
Shares repurchased by the Company and held as treasury stock (in shares)		(19,291)	(19,291)
Shares repurchased by the Company and held as treasury stock	(135)		$ (135)
Other comprehensive income	0
Stock-based compensation	6,721			6,721
Net income (loss)	(21,115)					(21,115)
Ending balance (in shares) at Sep. 30, 2024		17,868,489
Ending balance at Sep. 30, 2024	199,463	$ 1	$ (23,905)	1,219,628	0	(996,261)
Ending balance (in shares) at Sep. 30, 2024			4,133,469
Beginning balance (in shares) at Dec. 31, 2024		16,736,904
Beginning balance at Dec. 31, 2024	$ 173,036	$ 1	$ (32,349)	1,226,642	0	(1,021,258)
Beginning balance (in shares) at Dec. 31, 2024	5,400,000		5,416,418
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased by the Company and held as treasury stock (in shares)		(845,564)	(845,564)
Shares repurchased by the Company and held as treasury stock	$ (4,732)		$ (4,732)
Stock-based compensation	5,646			5,646
Net income (loss)	(17,142)					(17,142)
Ending balance (in shares) at Mar. 31, 2025		15,891,340
Ending balance at Mar. 31, 2025	156,808	$ 1	$ (37,081)	1,232,288	0	(1,038,400)
Ending balance (in shares) at Mar. 31, 2025			6,261,982
Beginning balance (in shares) at Dec. 31, 2024		16,736,904
Beginning balance at Dec. 31, 2024	$ 173,036	$ 1	$ (32,349)	1,226,642	0	(1,021,258)
Beginning balance (in shares) at Dec. 31, 2024	5,400,000		5,416,418
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	0
Other comprehensive income	$ 0
Net income (loss)	(52,506)
Ending balance (in shares) at Sep. 30, 2025		15,308,093
Ending balance at Sep. 30, 2025	$ 127,176	$ 1	$ (40,072)	1,241,011	0	(1,073,764)
Ending balance (in shares) at Sep. 30, 2025	6,800,000		6,849,640
Beginning balance (in shares) at Mar. 31, 2025		15,891,340
Beginning balance at Mar. 31, 2025	$ 156,808	$ 1	$ (37,081)	1,232,288	0	(1,038,400)
Beginning balance (in shares) at Mar. 31, 2025			6,261,982
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased by the Company and held as treasury stock (in shares)		(585,524)	(585,524)
Shares repurchased by the Company and held as treasury stock	(2,976)		$ (2,976)
Stock issued under employee stock purchase plan (in shares)		4,411
Stock issued under employee stock purchase plan	24			24
Stock-based compensation	4,409			4,409
Net income (loss)	(17,922)					(17,922)
Ending balance (in shares) at Jun. 30, 2025		15,310,227
Ending balance at Jun. 30, 2025	140,343	$ 1	$ (40,057)	1,236,721	0	(1,056,322)
Ending balance (in shares) at Jun. 30, 2025			6,847,506
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased by the Company and held as treasury stock (in shares)		(2,134)	(2,134)
Shares repurchased by the Company and held as treasury stock	(15)		$ (15)
Other comprehensive income	0
Stock-based compensation	4,290			4,290
Net income (loss)	(17,442)					(17,442)
Ending balance (in shares) at Sep. 30, 2025		15,308,093
Ending balance at Sep. 30, 2025	$ 127,176	$ 1	$ (40,072)	$ 1,241,011	$ 0	$ (1,073,764)
Ending balance (in shares) at Sep. 30, 2025	6,800,000		6,849,640